ALK + anaplastic large cell lymphoma involving the bladder: case report and review of the literature. [PDF]
Zhao Y, Qiu W, Weng X, Gu C, Li S.
europepmc +1 more source
Central nervous system relapse of primary cutaneous anaplastic large cell lymphoma: A case report. [PDF]
Mitsuyuki S +7 more
europepmc +1 more source
Primary Unilateral Adrenal Anaplastic Large Cell Lymphoma: Remission by Chemotherapy. [PDF]
Goto D +5 more
europepmc +1 more source
PTPN2 Inhibition Disrupts Mitochondrial Renewal and Blocks TFRC-Mediated Mitophagy to Exert Anti-Tumor Activities in ALK-Positive Anaplastic Large Cell Lymphoma. [PDF]
Wang WT +11 more
europepmc +1 more source
HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy. [PDF]
Zrimšek M +18 more
europepmc +1 more source
A rare case of circulating anaplastic lymphoma kinase-negative anaplastic large cell lymphoma. [PDF]
Chiriac R, Baseggio L.
europepmc +1 more source
Anaplastic Large Cell Lymphoma Growing in the Pacemaker Pocket. [PDF]
Adamo F +8 more
europepmc +1 more source
Successful Re-administration and Extended Dosing of Brentuximab Vedotin Monotherapy for Relapsed Anaplastic Large Cell Lymphoma in a Vulnerable Patient. [PDF]
Minemura T +9 more
europepmc +1 more source
Primary cutaneous anaplastic large cell lymphoma: Clinical response with low dose brentuximab vedotin on a patient receiving hemodialysis. [PDF]
Fason C, Tyring S, Huen AO.
europepmc +1 more source
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up. [PDF]
Domingo-Domènech E +26 more
europepmc +1 more source

